Sen. Sheldon Whitehouse

Maddy summaryThis bill raises the minimum age to purchase or possess certain firearms and large-capacity magazines from 18 to 21 years old. It specifically prohibits sales or transfers of "semiautomatic assault weapons" (including defined rifles, pistols, and shotguns with features like detachable magazines or specific attachments) and large-capacity magazines (holding more than 10 rounds) to anyone under 21. The bill directly affects individuals under 21 who would be barred from purchasing these items from licensed dealers. Limited exceptions exist for hunting, farming, military service, or self-defense, but the core change is a nationwide age restriction on these specific firearm types.

Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.

Emmett Till and Mamie Till-Mobley Congressional Gold Medal Act of 2021 This act provides for the posthumous presentation of a Congressional Gold Medal in commemoration of Emmett Till and Mamie Till-Mobley. After it is awarded, the medal shall be given to the National Museum of African American History and Culture.

Law Enforcement De-Escalation Training Act of 2022 This act directs the Department of Justice (DOJ) to develop scenario-based training curricula (or identify existing curricula) that includes topics such as alternatives to the use of force, de-escalation tactics, and safely responding to an individual experiencing a mental, behavioral health, or suicidal crisis. The act also directs DOJ to make grants to states for costs associated with providing the training to law enforcement officers or mental health professionals.

Justice and Mental Health Collaboration Reauthorization Act of 2022 This act expands the allowable use of grants under the Justice and Mental Health Collaboration Program. The program provides state, local, and tribal grants to improve the criminal justice system's response to people with mental health disorders. Among the provisions, the act allows funds for diversion and alternative prosecution and sentencing programs to be used for training for state and local prosecutors related to diversion programs; allows funds for multidisciplinary teams to be used to support police officers and mental health crisis workers responding together to mental health calls; and allows grants to be awarded for additional purposes such as suicide prevention programs and services, case management services, and state and local implementation of the 988 suicide hotline. Additionally, the act reauthorizes through FY2027 the requirement for the Department of Justice to examine and report on the prevalence of mentally ill offenders in prisons and jails.

Iran Hostages Congressional Gold Medal Act This bill provides for the award of a Congressional Gold Medal to the 53 hostages of the Iran Hostage Crisis (November 4, 1979-January 21, 1981) in recognition of their bravery and endurance throughout their captivity.

Save Our Seas 2.0 Amendments Act This bill revises provisions governing the administration of the Marine Debris Foundation and the Marine Debris Program. Specifically, the bill allows the foundation to use appropriated funds for employee salaries for the two years following the bill's enactment. The bill also allows the foundation to locate its principal office outside of the District of Columbia and encourages the foundation to locate it in a coastal state. In addition, the bill requires the foundation to develop best practices for conducting outreach to Indian tribes. The bill also requires the National Oceanic and Atmospheric Administration (NOAA) to approve appointments to the foundation's board of directors. NOAA may enter into other agreements, outside of contracts, under the Marine Debris Program. NOAA may also make in-kind contributions for projects under the program.

Maddy summarySRES 875 is a non-binding Senate resolution declaring racism a public health crisis in the United States. It directly affects racial and ethnic minority communities, which face documented health disparities including lower life expectancy, higher maternal mortality, and worse pandemic outcomes due to systemic inequities. The resolution commits the Senate to establishing a nationwide strategy to address health disparities, dismantle systemic racism, and advance reforms for communities disproportionately impacted by racism. It cites evidence from public health experts and historical data showing racism meets all criteria of a public health crisis: widespread impact, unfair distribution, preventable nature, and lack of current preventive measures. The resolution is symbolic, urging cross-government action but not creating new laws or funding.

Expanding the Voluntary Opportunities for Translations in Elections Act or the Expanding the VOTE Act This bill expands access to voting materials for individuals with limited proficiency in the English language, including by establishing incentive grants for states and political subdivisions to provide translated voting materials. Additionally, the bill directs the Government Accountability Office to study the impact of (1) reducing the threshold requirement under Section 203 of the Voting Rights Act of 1965, and (2) expanding the definition of language minorities to include native speakers of additional languages.

Medical Innovation Act of 2022 This bill requires certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a relevant settlement agreement regarding specified violations must pay 0.75%-1.5% of its net income to the Department of Health and Human Services for each of its covered blockbuster drugs. A covered blockbuster drug is a drug that has at least $1 billion in net sales in a year and was developed, in whole or in part, through federal investments in medical research. Payments are divided between the FDA and the NIH in proportion to the discretionary funding of those agencies, excluding FDA user fees. Payments are not disbursed if appropriations for the FDA or the NIH are lower than in the prior fiscal year. Priorities for payments must include advancing regulatory science for medical products and research related to diseases that disproportionately account for federal health care spending. A covered blockbuster drug for which a manufacturer has not made a required payment is considered misbranded and subject to prohibitions on introducing or receiving misbranded drugs in interstate commerce.